Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), IPHC, Université de Strasbourg, CNRS UMR7178 , 25 Rue Becquerel, Strasbourg F-67087, France.
CALIPHO Group, SIB-Swiss Institute of Bioinformatics, CMU , rue Michel-Servet 1, CH-1211 Geneva 4, Switzerland.
J Proteome Res. 2017 Dec 1;16(12):4340-4351. doi: 10.1021/acs.jproteome.7b00374. Epub 2017 Sep 26.
The present study is a contribution to the "neXt50 challenge", a coordinated effort across C-HPP teams to identify the 50 most tractable missing proteins (MPs) on each chromosome. We report the targeted search of 38 theoretically detectable MPs from chromosomes 2 and 14 in Triton X-100 soluble and insoluble sperm fractions from a total of 15 healthy donors. A targeted mass-spectrometry-based strategy consisting of the development of LC-PRM assays (with heavy labeled synthetic peptides) targeting 92 proteotypic peptides of the 38 selected MPs was used. Out of the 38 selected MPs, 12 were identified with two or more peptides and 3 with one peptide after extensive SDS-PAGE fractionation of the two samples and with overall low-intensity signals. The PRM data are available via ProteomeXchange in PASSEL (PASS01013). Further validation by immunohistochemistry on human testes sections and cytochemistry on sperm smears was performed for eight MPs with antibodies available from the Human Protein Atlas. Deep analysis of human sperm still allows the validation of MPs and therefore contributes to the C-HPP worldwide effort. We anticipate that our results will be of interest to the reproductive biology community because an in-depth analysis of these MPs may identify potential new candidates in the context of human idiopathic infertilities.
本研究是对“neXt50 挑战”的一项贡献,该挑战是 C-HPP 团队之间的协调努力,旨在确定每条染色体上最易处理的 50 种缺失蛋白(MPs)。我们报告了针对 Triton X-100 可溶性和不溶性精子分数中来自染色体 2 和 14 的 38 种理论上可检测的 MPs 的靶向搜索,来自总共 15 个健康供体。使用靶向质谱的策略,包括针对 38 种选定 MPs 的 92 种蛋白特征肽开发 LC-PRM 测定法(带有重标记的合成肽)。在对两种样品进行广泛的 SDS-PAGE 分级和总体低强度信号后,从 38 种选定的 MPs 中,有 12 种被鉴定出有两个或更多肽段,有 3 种被鉴定出有一种肽段。PRM 数据可通过 ProteomeXchange 在 PASSEL(PASS01013)中获得。对于 8 种可用人蛋白图谱抗体的 MPs,通过免疫组织化学对人睾丸切片和精子涂片细胞化学进行了进一步验证。对人类精子的深入分析仍然可以验证 MPs,因此为全球 C-HPP 做出了贡献。我们预计我们的结果将引起生殖生物学界的兴趣,因为对这些 MPs 的深入分析可能会在人类特发性不育症的背景下确定潜在的新候选者。